The Oncology Institute, Inc. (NASDAQ:TOIIW) Short Interest Update

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 4,700 shares, a growth of 4,600.0% from the October 31st total of 100 shares. Based on an average trading volume of 43,600 shares, the short-interest ratio is presently 0.1 days.

Oncology Institute Stock Performance

Oncology Institute stock remained flat at $0.01 during midday trading on Wednesday. The company had a trading volume of 41,556 shares, compared to its average volume of 35,084. Oncology Institute has a fifty-two week low of $0.01 and a fifty-two week high of $0.37. The business has a 50 day moving average of $0.02 and a 200-day moving average of $0.03.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.